Viewing Study NCT04916002

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-01-16 @ 12:47 AM
Study NCT ID: NCT04916002
Status: TERMINATED
Last Update Posted: 2025-12-05
First Post: 2021-06-01
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
Sponsor: Regeneron Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Merkel Cell Carcinoma View
None Cutaneous Squamous Cell Carcinoma View
None Basal Cell Carcinoma View
None Triple Negative Breast Cancer View
None Non-Small Cell Lung Cancer View
None Oropharynx Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None vidutolimod View
None Metastatic Cancer View
None Advanced Cancer View
None MCC View
None CSCC View
None BCC View
None TNBC View
None NSCLC View
None OPSCC View